WHO ICTRP trial
The prospective study of nivolumab for advanced NSCLC patients with mild IIPs
JPRN-UMIN000026129 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000026129 |
|---|---|
| Public title | The prospective study of nivolumab for advanced NSCLC patients with mild IIPs |
| Scientific title | The prospective study of nivolumab for advanced NSCLC patients with mild IIPs - The prospective study of nivolumab for advanced NSCLC patients with mild IIPs |
| Primary sponsor | Kobe city medical center general hospital |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | non-small cell lung cancer interstitial lung disease interstitial pneumonia |
| Interventions | Nivolumab 3mg/kg, every 2 weeks |
| Registration date | Feb 15, 2017 |
| Target size | 18 |
| Registry page | center6.umin.ac.jp |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: